Sharon Benzeno
Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $14.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 30SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 11,034272,751 held (−4%) | $21.00 | $232K | +26.1% |
| Jun 30SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 154,768221,278 held (−41%) | $21.14 | $3.3M | +25.3% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell | 63,103272,751 held (−19%) | $13.17 | $831K | +101.1% |
| Dec 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 12,604296,791 held (−4%) | $16.85 | $212K | +57.2% |
| Nov 24SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 297,925296,791 held (−50%) | $16.54 | $4.9M | +60.2% |
| Nov 24SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 308,477296,791 held (−51%) | $16.91 | $5.2M | +56.7% |
- Sell
Chief Commercial Ofc Imm Med Sharon Benzeno sold $232K of ADPT at $21.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Ofc Imm Med Sharon Benzeno sold $3.3M of ADPT at $21.14 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Ofc Imm Med Sharon Benzeno sold $212K of ADPT at $16.85 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Ofc Imm Med Sharon Benzeno sold $4.9M of ADPT at $16.54 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Ofc Imm Med Sharon Benzeno sold $5.2M of ADPT at $16.91 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.